- FoI Number
- 2023-431
- Subject
- Cancer Treatments
- Date Received
- 27/10/2023
- Request and Response
-
- Over the last 6 months, how many patients were treated with a combination of Dabrafenib + Trametinib for the following diseases:
- A) Metastatic Melanoma
- B) Adjuvant Melanoma
- C) BRAF mutated Lung Cancer
Zero
- Over the last 6 months, how many patients were treated with a combination of Encorafenib (Braftovi) + Binimetinib (Mektovi) for the following diseases:
- A) Metastatic Melanoma
- B) Colorectal Cancer
- C) Any other indications
Zero
